Welcome to the 3rd World Conference on Targeting Liver Diseases

Malta 2014 Pr Edeas Pr Safadi

After the success of the two previous editions, we are pleased to announce you the organization of the 3rd World Conference on Targeting Liver Diseases: Sciences, Clinical Innovations & Biotechnology to be held in Lisbon, Portugal in December 1 - 2, 2016.

 

 

Targeting Liver Diseases 2016 is not just another liver meeting to update in liver progress. However, we are  creating a kind of mind storming forum to create new therapeutic approaches that are targeting the liver.

Not only liver research and topics are proposed, but also other important research easing up a liver benefit. It could be research tools in other fields that implicate liver research, or important non liver pathways that are potential to be helpful in a future liver research. During Targeting Liver 2016, we will initiate new channels and fields such as Microbiota, Stem Cells, Mitochondria and wave them to liver homeostasis and pathologies.

Therefore, Targeting Liver Diseases 2016 is including also non liver topics to be exposed for the liver researchers to enrich knowledge. The same with the clinical and basic science combination that are coming to feed each side more proximity and leading to more focused research based on real needs.

Targeting Liver Diseases 2016 will be divided on two days:

Day One: Targeting Liver Diseases 2016: Recent Advances & Perspectives

  • Liver Diseases & Primary Sclerosing Cholangitis
  •  Liver Diseases & Cancer
  • Liver Diseases, Oxidative Stress, Mitochondria & Microbiota
  • Liver Diseases & Endotoxins
  • Liver Transplantation
  • Liver Diseases & Fibrosis
  • Fatty Liver Diseases
  • Liver Diseases & Viral Infection

Day Two: Targeting Liver Diseases 2016: The Innovations

Targeting Liver 2016 : new targets and therapies in liver diseases

Targeting Liver 2016 will provide a unique and rare opportunity for interactions between industry and liver disease experts. Seeking to help identify unmet needs in hepatology, these 2 days will look toward the future to determine how to address the long-term challenges that hepatologists are likely to face in the coming years. 

We look forward to meet you in sunny Lisbon next July.

Prof. Marvin Edeas - Prof. Rifaat Safadi
Chairmen of the Scientific Committee